BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 30228301)

  • 1. Stem cell fate in cancer growth, progression and therapy resistance.
    Lytle NK; Barber AG; Reya T
    Nat Rev Cancer; 2018 Nov; 18(11):669-680. PubMed ID: 30228301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells in cancer initiation and progression.
    Bajaj J; Diaz E; Reya T
    J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31874116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer.
    Ferguson LP; Diaz E; Reya T
    Trends Cancer; 2021 Jul; 7(7):624-634. PubMed ID: 33509688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell origin of cancer and differentiation therapy.
    Sell S
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):1-28. PubMed ID: 15207251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour heterogeneity and cancer cell plasticity.
    Meacham CE; Morrison SJ
    Nature; 2013 Sep; 501(7467):328-37. PubMed ID: 24048065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.
    Mimeault M; Hauke R; Mehta PP; Batra SK
    J Cell Mol Med; 2007; 11(5):981-1011. PubMed ID: 17979879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells and human malignant melanoma.
    Schatton T; Frank MH
    Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer initiating cell theory: popularity and controversies].
    Chen H; Huang Q; Dong J; Lan Q
    Ai Zheng; 2006 Jun; 25(6):779-84. PubMed ID: 16764781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life style factors, tumor cell plasticity and cancer stem cells.
    Chiodi I; Mondello C
    Mutat Res Rev Mutat Res; 2020; 784():108308. PubMed ID: 32430096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of cancer stem cells.
    Bapat SA
    Semin Cancer Biol; 2007 Jun; 17(3):204-13. PubMed ID: 16787749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stem cell niche in health and malignancy.
    Burness ML; Sipkins DA
    Semin Cancer Biol; 2010 Apr; 20(2):107-15. PubMed ID: 20510363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cyclic hypoxia to prevent malignant progression and therapeutic resistance of cancers.
    Sun Q; Li X
    Histol Histopathol; 2015 Jan; 30(1):51-60. PubMed ID: 25050739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.
    Mimeault M; Batra SK
    Panminerva Med; 2008 Mar; 50(1):3-18. PubMed ID: 18427384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of cancers. Clinical perspectives and implications of a stem-cell theory of cancer.
    Tu SM
    Cancer Treat Res; 2010; 154():v-239. PubMed ID: 20645140
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cells: promises and realities in cancer research.
    García-Olmo D; García-Olmo DC
    Clin Transl Oncol; 2006 May; 8(5):301-2. PubMed ID: 16760002
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.
    Kakarala M; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2813-20. PubMed ID: 18539959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
    Mimeault M; Batra SK
    Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.